In vivo therapeutic blockade of PD-1 in a mouse model greatly improves growth control of αV-knockout tumours via a mechanism involving increased tumour infiltration by activated tumour-specific CD103+CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.